of contracts through the years, including those with the FAA, U.S. Navy, and the Department of Defense. The company reported Q3 earnings that showed $3.24 billion in revenue, and year-over-year growth of 14.4%.

But the company has also been fighting to hang on to a few recently awarded contracts. Leidos won a $7.7 billion contract in February to provide services for the Navy’s NGEN program. But Perspecta, the incumbent contractor, filed a lawsuit against the Navy in early July, threatening to delay the scheduled changeover. In addition, Leidos is battling to keep a $147 million Housing and Urban Development IT modernization contract. This time, the company is protesting the fact that Perspecta has won it at least twice.

In the meantime, the Leidos Partnership for Defense Health just announced that it has continued deployments of the MHS Genesis electronic health records system to military treatment facilities (MTFs) in Nevada, California, and Alaska. The program replaces the military’s existing health records software, and when fully deployed, MHS GENESIS will be able to provide a single solution for millions of service members and their families.

The system is currently live and operational across 20 MTF commands, with the latest deployment, Wave PENDLETON, going live in late October with sites in California and Alaska. Recent deployment activity also included the first of three waves for the U.S. Coast Guard (USCG), which added approximately 100 USCG users, with additional waves scheduled for Go-Live next year. The system will eventually be rolled out to all 43 ashore clinics and 67 ashore sick bays.

“We proudly and safely delivered MHS GENESIS on schedule amid a global pandemic,” said Liz Porter, Leidos Health Group President. “These latest deployments have enabled nearly 10,000 clinicians and providers to access a single, common health record during this critical time for our nation.”

This news follows Leidos’ recent announcement that it was awarded an $82 million contract by the Naval Medical Logistics Command. Through this contract, Leidos will continue to perform operational medicine and warfighter performance research for the Naval Health Research Center’s (NHRC) Operational Readiness Directorate.